nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ovarian cancer—cervical cancer	0.457	1	CtDrD
Docetaxel—EGFR—cervical cancer	0.266	1	CbGaD
Docetaxel—ABCG2—Topotecan—cervical cancer	0.0755	0.634	CbGbCtD
Docetaxel—ABCB1—Topotecan—cervical cancer	0.0272	0.229	CbGbCtD
Docetaxel—CYP3A4—Topotecan—cervical cancer	0.0163	0.137	CbGbCtD
Docetaxel—Neutropenic colitis—Topotecan—cervical cancer	0.00643	0.108	CcSEcCtD
Docetaxel—Metastatic neoplasm—Topotecan—cervical cancer	0.00387	0.0651	CcSEcCtD
Docetaxel—Lung neoplasm malignant—Topotecan—cervical cancer	0.00369	0.0622	CcSEcCtD
Docetaxel—Acute respiratory distress syndrome—Topotecan—cervical cancer	0.00284	0.0478	CcSEcCtD
Docetaxel—Acute leukaemia—Topotecan—cervical cancer	0.00259	0.0437	CcSEcCtD
Docetaxel—Bullous eruption—Topotecan—cervical cancer	0.00188	0.0316	CcSEcCtD
Docetaxel—KIF11—Irinotecan—Topotecan—cervical cancer	0.00165	0.58	CbGdCrCtD
Docetaxel—Myelosuppression—Topotecan—cervical cancer	0.00158	0.0266	CcSEcCtD
Docetaxel—KIF11—endometrium—cervical cancer	0.00158	0.0292	CbGeAlD
Docetaxel—KIF11—mammalian vulva—cervical cancer	0.00153	0.0282	CbGeAlD
Docetaxel—Mucosal inflammation—Topotecan—cervical cancer	0.00134	0.0225	CcSEcCtD
Docetaxel—KIF11—female reproductive system—cervical cancer	0.00131	0.0242	CbGeAlD
Docetaxel—Febrile neutropenia—Topotecan—cervical cancer	0.00123	0.0207	CcSEcCtD
Docetaxel—BCL2—Irinotecan—Topotecan—cervical cancer	0.0012	0.42	CbGdCrCtD
Docetaxel—KIF11—female gonad—cervical cancer	0.00119	0.022	CbGeAlD
Docetaxel—KIF11—vagina—cervical cancer	0.00118	0.0218	CbGeAlD
Docetaxel—Intestinal obstruction—Topotecan—cervical cancer	0.00109	0.0183	CcSEcCtD
Docetaxel—Heartburn—Topotecan—cervical cancer	0.00108	0.0181	CcSEcCtD
Docetaxel—Neuralgia—Topotecan—cervical cancer	0.00107	0.018	CcSEcCtD
Docetaxel—Interstitial lung disease—Topotecan—cervical cancer	0.00105	0.0176	CcSEcCtD
Docetaxel—Pleural effusion—Topotecan—cervical cancer	0.000968	0.0163	CcSEcCtD
Docetaxel—Rash erythematous—Topotecan—cervical cancer	0.000968	0.0163	CcSEcCtD
Docetaxel—Rigors—Topotecan—cervical cancer	0.000908	0.0153	CcSEcCtD
Docetaxel—Extravasation—Topotecan—cervical cancer	0.00085	0.0143	CcSEcCtD
Docetaxel—Hyperbilirubinaemia—Topotecan—cervical cancer	0.000815	0.0137	CcSEcCtD
Docetaxel—MAP4—uterine cervix—cervical cancer	0.000805	0.0149	CbGeAlD
Docetaxel—Blood bilirubin increased—Topotecan—cervical cancer	0.000784	0.0132	CcSEcCtD
Docetaxel—Bone pain—Topotecan—cervical cancer	0.000774	0.013	CcSEcCtD
Docetaxel—MAP4—decidua—cervical cancer	0.000767	0.0142	CbGeAlD
Docetaxel—KIF11—lymph node—cervical cancer	0.000765	0.0141	CbGeAlD
Docetaxel—Respiratory failure—Topotecan—cervical cancer	0.000755	0.0127	CcSEcCtD
Docetaxel—MAP4—renal system—cervical cancer	0.000753	0.0139	CbGeAlD
Docetaxel—TUBB1—decidua—cervical cancer	0.00075	0.0138	CbGeAlD
Docetaxel—Pulmonary embolism—Topotecan—cervical cancer	0.000741	0.0125	CcSEcCtD
Docetaxel—BCL2—epithelium—cervical cancer	0.000738	0.0136	CbGeAlD
Docetaxel—EGFR—uterine cervix—cervical cancer	0.000723	0.0133	CbGeAlD
Docetaxel—Colitis—Topotecan—cervical cancer	0.000712	0.012	CcSEcCtD
Docetaxel—Neuropathy—Topotecan—cervical cancer	0.000696	0.0117	CcSEcCtD
Docetaxel—BCL2—renal system—cervical cancer	0.000684	0.0126	CbGeAlD
Docetaxel—MAP4—uterus—cervical cancer	0.000671	0.0124	CbGeAlD
Docetaxel—Neoplasm—Topotecan—cervical cancer	0.00067	0.0113	CcSEcCtD
Docetaxel—BCL2—endometrium—cervical cancer	0.000661	0.0122	CbGeAlD
Docetaxel—Sepsis—Topotecan—cervical cancer	0.000643	0.0108	CcSEcCtD
Docetaxel—MAP2—uterine cervix—cervical cancer	0.000634	0.0117	CbGeAlD
Docetaxel—EGFR—mammalian vulva—cervical cancer	0.000632	0.0117	CbGeAlD
Docetaxel—BCL2—uterus—cervical cancer	0.00061	0.0113	CbGeAlD
Docetaxel—MAP2—decidua—cervical cancer	0.000604	0.0111	CbGeAlD
Docetaxel—MAP4—female reproductive system—cervical cancer	0.000603	0.0111	CbGeAlD
Docetaxel—EGFR—uterus—cervical cancer	0.000602	0.0111	CbGeAlD
Docetaxel—MAP2—endometrium—cervical cancer	0.000573	0.0106	CbGeAlD
Docetaxel—Dermatitis bullous—Topotecan—cervical cancer	0.000563	0.00948	CcSEcCtD
Docetaxel—MAP2—mammalian vulva—cervical cancer	0.000554	0.0102	CbGeAlD
Docetaxel—Lethargy—Topotecan—cervical cancer	0.000549	0.00924	CcSEcCtD
Docetaxel—MAP4—female gonad—cervical cancer	0.000549	0.0101	CbGeAlD
Docetaxel—BCL2—female reproductive system—cervical cancer	0.000548	0.0101	CbGeAlD
Docetaxel—MAP4—vagina—cervical cancer	0.000545	0.0101	CbGeAlD
Docetaxel—SLC22A7—renal system—cervical cancer	0.000512	0.00946	CbGeAlD
Docetaxel—BCL2—female gonad—cervical cancer	0.000499	0.00921	CbGeAlD
Docetaxel—EGFR—female gonad—cervical cancer	0.000493	0.0091	CbGeAlD
Docetaxel—TUBB4A—uterine cervix—cervical cancer	0.00049	0.00904	CbGeAlD
Docetaxel—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.000485	0.00816	CcSEcCtD
Docetaxel—Cramp muscle—Topotecan—cervical cancer	0.000485	0.00816	CcSEcCtD
Docetaxel—SLCO1B3—vagina—cervical cancer	0.000477	0.00881	CbGeAlD
Docetaxel—MAP2—female reproductive system—cervical cancer	0.000475	0.00877	CbGeAlD
Docetaxel—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000475	0.00799	CcSEcCtD
Docetaxel—TUBB2B—uterine cervix—cervical cancer	0.000473	0.00874	CbGeAlD
Docetaxel—TUBB4A—renal system—cervical cancer	0.000458	0.00846	CbGeAlD
Docetaxel—MAPT—lymph node—cervical cancer	0.000449	0.00828	CbGeAlD
Docetaxel—TUBB—uterine cervix—cervical cancer	0.000448	0.00827	CbGeAlD
Docetaxel—TUBB2A—uterine cervix—cervical cancer	0.000445	0.00823	CbGeAlD
Docetaxel—TUBB6—epithelium—cervical cancer	0.000443	0.00818	CbGeAlD
Docetaxel—TUBB2B—renal system—cervical cancer	0.000443	0.00818	CbGeAlD
Docetaxel—Pancytopenia—Topotecan—cervical cancer	0.000442	0.00743	CcSEcCtD
Docetaxel—TUBB6—uterine cervix—cervical cancer	0.000439	0.00811	CbGeAlD
Docetaxel—Neutropenia—Topotecan—cervical cancer	0.000435	0.00732	CcSEcCtD
Docetaxel—MAP2—female gonad—cervical cancer	0.000432	0.00798	CbGeAlD
Docetaxel—MAP2—vagina—cervical cancer	0.000429	0.00793	CbGeAlD
Docetaxel—TUBB2B—endometrium—cervical cancer	0.000428	0.0079	CbGeAlD
Docetaxel—TUBB—decidua—cervical cancer	0.000427	0.00788	CbGeAlD
Docetaxel—TUBB2A—decidua—cervical cancer	0.000424	0.00784	CbGeAlD
Docetaxel—Weight increased—Topotecan—cervical cancer	0.000423	0.00712	CcSEcCtD
Docetaxel—TUBB6—decidua—cervical cancer	0.000419	0.00773	CbGeAlD
Docetaxel—Pneumonia—Topotecan—cervical cancer	0.000417	0.00702	CcSEcCtD
Docetaxel—Infestation—Topotecan—cervical cancer	0.000415	0.00698	CcSEcCtD
Docetaxel—Infestation NOS—Topotecan—cervical cancer	0.000415	0.00698	CcSEcCtD
Docetaxel—TUBB2B—mammalian vulva—cervical cancer	0.000414	0.00765	CbGeAlD
Docetaxel—TUBB6—renal system—cervical cancer	0.000411	0.00759	CbGeAlD
Docetaxel—TUBB4A—uterus—cervical cancer	0.000408	0.00754	CbGeAlD
Docetaxel—Neuropathy peripheral—Topotecan—cervical cancer	0.000406	0.00684	CcSEcCtD
Docetaxel—TUBB—endometrium—cervical cancer	0.000405	0.00748	CbGeAlD
Docetaxel—Stomatitis—Topotecan—cervical cancer	0.000404	0.0068	CcSEcCtD
Docetaxel—TUBB2A—endometrium—cervical cancer	0.000403	0.00744	CbGeAlD
Docetaxel—TUBB6—endometrium—cervical cancer	0.000397	0.00734	CbGeAlD
Docetaxel—Hepatobiliary disease—Topotecan—cervical cancer	0.000392	0.0066	CcSEcCtD
Docetaxel—TUBB—mammalian vulva—cervical cancer	0.000392	0.00723	CbGeAlD
Docetaxel—Epistaxis—Topotecan—cervical cancer	0.000391	0.00658	CcSEcCtD
Docetaxel—TUBB2A—mammalian vulva—cervical cancer	0.00039	0.0072	CbGeAlD
Docetaxel—ABCC10—uterine cervix—cervical cancer	0.000385	0.0071	CbGeAlD
Docetaxel—TUBB6—mammalian vulva—cervical cancer	0.000384	0.0071	CbGeAlD
Docetaxel—TUBB4B—uterine cervix—cervical cancer	0.000382	0.00705	CbGeAlD
Docetaxel—Haemoglobin—Topotecan—cervical cancer	0.000374	0.0063	CcSEcCtD
Docetaxel—TUBB—uterus—cervical cancer	0.000373	0.00689	CbGeAlD
Docetaxel—Rhinitis—Topotecan—cervical cancer	0.000373	0.00628	CcSEcCtD
Docetaxel—Haemorrhage—Topotecan—cervical cancer	0.000372	0.00627	CcSEcCtD
Docetaxel—TUBB2A—uterus—cervical cancer	0.000371	0.00686	CbGeAlD
Docetaxel—Hypoaesthesia—Topotecan—cervical cancer	0.00037	0.00623	CcSEcCtD
Docetaxel—Pharyngitis—Topotecan—cervical cancer	0.000369	0.00622	CcSEcCtD
Docetaxel—TUBB4A—female reproductive system—cervical cancer	0.000367	0.00677	CbGeAlD
Docetaxel—ABCC10—decidua—cervical cancer	0.000366	0.00677	CbGeAlD
Docetaxel—TUBB6—uterus—cervical cancer	0.000366	0.00676	CbGeAlD
Docetaxel—TUBB4B—decidua—cervical cancer	0.000364	0.00672	CbGeAlD
Docetaxel—ABCC10—renal system—cervical cancer	0.00036	0.00665	CbGeAlD
Docetaxel—TUBB4B—renal system—cervical cancer	0.000357	0.0066	CbGeAlD
Docetaxel—TUBB2B—female reproductive system—cervical cancer	0.000355	0.00655	CbGeAlD
Docetaxel—MAP4—lymph node—cervical cancer	0.000353	0.00651	CbGeAlD
Docetaxel—ABCC10—endometrium—cervical cancer	0.000348	0.00642	CbGeAlD
Docetaxel—TUBB4B—endometrium—cervical cancer	0.000345	0.00638	CbGeAlD
Docetaxel—Angiopathy—Topotecan—cervical cancer	0.000338	0.00568	CcSEcCtD
Docetaxel—ABCC10—mammalian vulva—cervical cancer	0.000337	0.00621	CbGeAlD
Docetaxel—Immune system disorder—Topotecan—cervical cancer	0.000336	0.00566	CcSEcCtD
Docetaxel—Mediastinal disorder—Topotecan—cervical cancer	0.000335	0.00565	CcSEcCtD
Docetaxel—TUBB4B—mammalian vulva—cervical cancer	0.000334	0.00617	CbGeAlD
Docetaxel—Chills—Topotecan—cervical cancer	0.000334	0.00562	CcSEcCtD
Docetaxel—TUBB4A—female gonad—cervical cancer	0.000334	0.00616	CbGeAlD
Docetaxel—TUBB2A—female reproductive system—cervical cancer	0.000334	0.00616	CbGeAlD
Docetaxel—TUBB6—female reproductive system—cervical cancer	0.000329	0.00608	CbGeAlD
Docetaxel—Alopecia—Topotecan—cervical cancer	0.000329	0.00554	CcSEcCtD
Docetaxel—Malnutrition—Topotecan—cervical cancer	0.000324	0.00545	CcSEcCtD
Docetaxel—TUBB2B—female gonad—cervical cancer	0.000323	0.00596	CbGeAlD
Docetaxel—TUBB2B—vagina—cervical cancer	0.000321	0.00592	CbGeAlD
Docetaxel—ABCC10—uterus—cervical cancer	0.000321	0.00592	CbGeAlD
Docetaxel—BCL2—lymph node—cervical cancer	0.000321	0.00592	CbGeAlD
Docetaxel—TUBB4B—uterus—cervical cancer	0.000318	0.00588	CbGeAlD
Docetaxel—EGFR—lymph node—cervical cancer	0.000317	0.00585	CbGeAlD
Docetaxel—Back pain—Topotecan—cervical cancer	0.000313	0.00528	CcSEcCtD
Docetaxel—Muscle spasms—Topotecan—cervical cancer	0.000312	0.00524	CcSEcCtD
Docetaxel—TUBB—female gonad—cervical cancer	0.000305	0.00564	CbGeAlD
Docetaxel—TUBB2A—female gonad—cervical cancer	0.000304	0.00561	CbGeAlD
Docetaxel—TUBB—vagina—cervical cancer	0.000303	0.0056	CbGeAlD
Docetaxel—TUBB2A—vagina—cervical cancer	0.000302	0.00557	CbGeAlD
Docetaxel—TUBB6—female gonad—cervical cancer	0.0003	0.00553	CbGeAlD
Docetaxel—Anaemia—Topotecan—cervical cancer	0.000299	0.00504	CcSEcCtD
Docetaxel—TUBB6—vagina—cervical cancer	0.000298	0.0055	CbGeAlD
Docetaxel—Leukopenia—Topotecan—cervical cancer	0.00029	0.00488	CcSEcCtD
Docetaxel—ABCC2—renal system—cervical cancer	0.000289	0.00534	CbGeAlD
Docetaxel—ABCC10—female reproductive system—cervical cancer	0.000288	0.00532	CbGeAlD
Docetaxel—CYP1B1—decidua—cervical cancer	0.000288	0.00532	CbGeAlD
Docetaxel—TUBB4B—female reproductive system—cervical cancer	0.000286	0.00528	CbGeAlD
Docetaxel—CYP1B1—renal system—cervical cancer	0.000283	0.00523	CbGeAlD
Docetaxel—Cough—Topotecan—cervical cancer	0.000283	0.00476	CcSEcCtD
Docetaxel—MAP2—lymph node—cervical cancer	0.000278	0.00513	CbGeAlD
Docetaxel—Myalgia—Topotecan—cervical cancer	0.000276	0.00464	CcSEcCtD
Docetaxel—Chest pain—Topotecan—cervical cancer	0.000276	0.00464	CcSEcCtD
Docetaxel—Arthralgia—Topotecan—cervical cancer	0.000276	0.00464	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000274	0.00461	CcSEcCtD
Docetaxel—ABCC1—uterine cervix—cervical cancer	0.000272	0.00502	CbGeAlD
Docetaxel—Anaphylactic shock—Topotecan—cervical cancer	0.000264	0.00445	CcSEcCtD
Docetaxel—Infection—Topotecan—cervical cancer	0.000263	0.00442	CcSEcCtD
Docetaxel—ABCC10—female gonad—cervical cancer	0.000262	0.00484	CbGeAlD
Docetaxel—ABCC10—vagina—cervical cancer	0.000261	0.00481	CbGeAlD
Docetaxel—TUBB4B—female gonad—cervical cancer	0.00026	0.00481	CbGeAlD
Docetaxel—Nervous system disorder—Topotecan—cervical cancer	0.000259	0.00437	CcSEcCtD
Docetaxel—ABCC1—decidua—cervical cancer	0.000259	0.00479	CbGeAlD
Docetaxel—Thrombocytopenia—Topotecan—cervical cancer	0.000259	0.00436	CcSEcCtD
Docetaxel—TUBB4B—vagina—cervical cancer	0.000259	0.00478	CbGeAlD
Docetaxel—Skin disorder—Topotecan—cervical cancer	0.000257	0.00432	CcSEcCtD
Docetaxel—CYP1B1—uterus—cervical cancer	0.000252	0.00466	CbGeAlD
Docetaxel—Anorexia—Topotecan—cervical cancer	0.000252	0.00424	CcSEcCtD
Docetaxel—ABCC1—endometrium—cervical cancer	0.000246	0.00454	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000241	0.00406	CcSEcCtD
Docetaxel—ABCC1—mammalian vulva—cervical cancer	0.000238	0.0044	CbGeAlD
Docetaxel—Paraesthesia—Topotecan—cervical cancer	0.000237	0.004	CcSEcCtD
Docetaxel—Dyspnoea—Topotecan—cervical cancer	0.000236	0.00397	CcSEcCtD
Docetaxel—Dyspepsia—Topotecan—cervical cancer	0.000233	0.00392	CcSEcCtD
Docetaxel—ABCC2—female reproductive system—cervical cancer	0.000231	0.00427	CbGeAlD
Docetaxel—Decreased appetite—Topotecan—cervical cancer	0.00023	0.00387	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Topotecan—cervical cancer	0.000228	0.00384	CcSEcCtD
Docetaxel—Fatigue—Topotecan—cervical cancer	0.000228	0.00384	CcSEcCtD
Docetaxel—ABCC1—uterus—cervical cancer	0.000227	0.00419	CbGeAlD
Docetaxel—CYP1B1—female reproductive system—cervical cancer	0.000227	0.00419	CbGeAlD
Docetaxel—Pain—Topotecan—cervical cancer	0.000226	0.00381	CcSEcCtD
Docetaxel—Constipation—Topotecan—cervical cancer	0.000226	0.00381	CcSEcCtD
Docetaxel—ABCG2—uterine cervix—cervical cancer	0.000225	0.00416	CbGeAlD
Docetaxel—Feeling abnormal—Topotecan—cervical cancer	0.000218	0.00367	CcSEcCtD
Docetaxel—Gastrointestinal pain—Topotecan—cervical cancer	0.000216	0.00364	CcSEcCtD
Docetaxel—ABCG2—decidua—cervical cancer	0.000215	0.00396	CbGeAlD
Docetaxel—TUBB4A—lymph node—cervical cancer	0.000215	0.00396	CbGeAlD
Docetaxel—CYP3A5—uterine cervix—cervical cancer	0.000209	0.00386	CbGeAlD
Docetaxel—Body temperature increased—Topotecan—cervical cancer	0.000209	0.00352	CcSEcCtD
Docetaxel—Abdominal pain—Topotecan—cervical cancer	0.000209	0.00352	CcSEcCtD
Docetaxel—TUBB2B—lymph node—cervical cancer	0.000207	0.00383	CbGeAlD
Docetaxel—CYP1B1—female gonad—cervical cancer	0.000206	0.00381	CbGeAlD
Docetaxel—ABCG2—endometrium—cervical cancer	0.000204	0.00376	CbGeAlD
Docetaxel—ABCG2—mammalian vulva—cervical cancer	0.000197	0.00364	CbGeAlD
Docetaxel—TUBB—lymph node—cervical cancer	0.000196	0.00362	CbGeAlD
Docetaxel—CYP3A5—renal system—cervical cancer	0.000196	0.00361	CbGeAlD
Docetaxel—TUBB2A—lymph node—cervical cancer	0.000195	0.00361	CbGeAlD
Docetaxel—Hypersensitivity—Topotecan—cervical cancer	0.000195	0.00328	CcSEcCtD
Docetaxel—TUBB6—lymph node—cervical cancer	0.000193	0.00356	CbGeAlD
Docetaxel—Asthenia—Topotecan—cervical cancer	0.00019	0.00319	CcSEcCtD
Docetaxel—ABCG2—uterus—cervical cancer	0.000188	0.00347	CbGeAlD
Docetaxel—Pruritus—Topotecan—cervical cancer	0.000187	0.00315	CcSEcCtD
Docetaxel—ABCC1—female gonad—cervical cancer	0.000185	0.00343	CbGeAlD
Docetaxel—ABCC1—vagina—cervical cancer	0.000184	0.0034	CbGeAlD
Docetaxel—Diarrhoea—Topotecan—cervical cancer	0.000181	0.00305	CcSEcCtD
Docetaxel—Dizziness—Topotecan—cervical cancer	0.000175	0.00294	CcSEcCtD
Docetaxel—ABCC10—lymph node—cervical cancer	0.000169	0.00311	CbGeAlD
Docetaxel—Vomiting—Topotecan—cervical cancer	0.000168	0.00283	CcSEcCtD
Docetaxel—TUBB4B—lymph node—cervical cancer	0.000167	0.00309	CbGeAlD
Docetaxel—Rash—Topotecan—cervical cancer	0.000167	0.00281	CcSEcCtD
Docetaxel—Dermatitis—Topotecan—cervical cancer	0.000167	0.0028	CcSEcCtD
Docetaxel—Headache—Topotecan—cervical cancer	0.000166	0.00279	CcSEcCtD
Docetaxel—Nausea—Topotecan—cervical cancer	0.000157	0.00264	CcSEcCtD
Docetaxel—ABCG2—female gonad—cervical cancer	0.000154	0.00284	CbGeAlD
Docetaxel—ABCG2—vagina—cervical cancer	0.000153	0.00282	CbGeAlD
Docetaxel—CYP3A4—renal system—cervical cancer	0.000147	0.00271	CbGeAlD
Docetaxel—CYP3A5—female gonad—cervical cancer	0.000143	0.00263	CbGeAlD
Docetaxel—CYP3A5—vagina—cervical cancer	0.000142	0.00262	CbGeAlD
Docetaxel—ABCC2—lymph node—cervical cancer	0.000135	0.0025	CbGeAlD
Docetaxel—CYP1B1—lymph node—cervical cancer	0.000133	0.00245	CbGeAlD
Docetaxel—ABCC1—lymph node—cervical cancer	0.000119	0.0022	CbGeAlD
Docetaxel—CYP3A4—female reproductive system—cervical cancer	0.000118	0.00217	CbGeAlD
Docetaxel—ABCB1—epithelium—cervical cancer	0.000112	0.00207	CbGeAlD
Docetaxel—ABCB1—uterine cervix—cervical cancer	0.000111	0.00205	CbGeAlD
Docetaxel—ABCB1—decidua—cervical cancer	0.000106	0.00195	CbGeAlD
Docetaxel—ABCB1—renal system—cervical cancer	0.000104	0.00192	CbGeAlD
Docetaxel—ABCB1—endometrium—cervical cancer	0.0001	0.00186	CbGeAlD
Docetaxel—ABCG2—lymph node—cervical cancer	9.87e-05	0.00182	CbGeAlD
Docetaxel—ABCB1—mammalian vulva—cervical cancer	9.72e-05	0.00179	CbGeAlD
Docetaxel—ABCB1—uterus—cervical cancer	9.26e-05	0.00171	CbGeAlD
Docetaxel—ABCB1—female reproductive system—cervical cancer	8.32e-05	0.00154	CbGeAlD
Docetaxel—ABCB1—female gonad—cervical cancer	7.57e-05	0.0014	CbGeAlD
Docetaxel—ABCB1—vagina—cervical cancer	7.53e-05	0.00139	CbGeAlD
Docetaxel—EGFR—Signaling events mediated by PTP1B—STAT3—cervical cancer	5.07e-05	0.00125	CbGpPWpGaD
Docetaxel—EGFR—AGE/RAGE pathway—CASP3—cervical cancer	4.99e-05	0.00123	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—EGFR—cervical cancer	4.96e-05	0.00122	CbGpPWpGaD
Docetaxel—ABCB1—lymph node—cervical cancer	4.87e-05	0.000899	CbGeAlD
Docetaxel—NR1I2—Gene Expression—RARB—cervical cancer	4.85e-05	0.00119	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.76e-05	0.00117	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	4.75e-05	0.00117	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—MTOR—cervical cancer	4.73e-05	0.00116	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	4.48e-05	0.0011	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—cervical cancer	4.46e-05	0.0011	CbGpPWpGaD
Docetaxel—MAPT—Apoptosis—TP53—cervical cancer	4.44e-05	0.00109	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	4.41e-05	0.00108	CbGpPWpGaD
Docetaxel—EGFR—Constitutive PI3K/AKT Signaling in Cancer—MTOR—cervical cancer	4.39e-05	0.00108	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CASP8—cervical cancer	4.39e-05	0.00108	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—CASP3—cervical cancer	4.35e-05	0.00107	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NOTCH2—cervical cancer	4.28e-05	0.00105	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—CASP3—cervical cancer	4.26e-05	0.00105	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	4.24e-05	0.00104	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—FGFR3—cervical cancer	4.2e-05	0.00103	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	4.19e-05	0.00103	CbGpPWpGaD
Docetaxel—EGFR—AGE/RAGE pathway—STAT3—cervical cancer	4.19e-05	0.00103	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis Modulation and Signaling—TP53—cervical cancer	4.18e-05	0.00103	CbGpPWpGaD
Docetaxel—KIF11—Adaptive Immune System—EGFR—cervical cancer	4.18e-05	0.00103	CbGpPWpGaD
Docetaxel—MAPT—MAPK Signaling Pathway—TP53—cervical cancer	4.17e-05	0.00102	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	4.14e-05	0.00102	CbGpPWpGaD
Docetaxel—NR1I2—Generic Transcription Pathway—NOTCH1—cervical cancer	4.13e-05	0.00101	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—CTNNB1—cervical cancer	4.11e-05	0.00101	CbGpPWpGaD
Docetaxel—KIF11—Hemostasis—TP53—cervical cancer	4.06e-05	0.000997	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—FGFR3—cervical cancer	4.02e-05	0.000987	CbGpPWpGaD
Docetaxel—EGFR—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	4.02e-05	0.000987	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—FGFR3—cervical cancer	3.95e-05	0.000971	CbGpPWpGaD
Docetaxel—EGFR—PI-3K cascade—MTOR—cervical cancer	3.95e-05	0.000971	CbGpPWpGaD
Docetaxel—EGFR—PI3K/AKT activation—MTOR—cervical cancer	3.86e-05	0.000948	CbGpPWpGaD
Docetaxel—EGFR—GAB1 signalosome—MTOR—cervical cancer	3.83e-05	0.00094	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.81e-05	0.000935	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	3.78e-05	0.00093	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—FGFR3—cervical cancer	3.78e-05	0.000928	CbGpPWpGaD
Docetaxel—BCL2—Immune System—UBE3A—cervical cancer	3.76e-05	0.000925	CbGpPWpGaD
Docetaxel—MAPT—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.76e-05	0.000924	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—FGFR3—cervical cancer	3.76e-05	0.000923	CbGpPWpGaD
Docetaxel—EGFR—ErbB Signaling Pathway—TP53—cervical cancer	3.75e-05	0.000922	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—MTOR—cervical cancer	3.74e-05	0.000919	CbGpPWpGaD
Docetaxel—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—MTOR—cervical cancer	3.74e-05	0.000919	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—FGFR3—cervical cancer	3.74e-05	0.000919	CbGpPWpGaD
Docetaxel—BCL2—Senescence and Autophagy in Cancer—TP53—cervical cancer	3.73e-05	0.000917	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—FGFR3—cervical cancer	3.72e-05	0.000914	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—UBE3A—cervical cancer	3.67e-05	0.000901	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cervical cancer	3.67e-05	0.000901	CbGpPWpGaD
Docetaxel—BCL2—DNA Damage Response (only ATM dependent)—TP53—cervical cancer	3.62e-05	0.000889	CbGpPWpGaD
Docetaxel—KIF11—Immune System—MTOR—cervical cancer	3.61e-05	0.000887	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.61e-05	0.000886	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CD4—cervical cancer	3.6e-05	0.000885	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—EGFR—cervical cancer	3.53e-05	0.000867	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HES1—cervical cancer	3.51e-05	0.000862	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—FGFR3—cervical cancer	3.5e-05	0.00086	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	3.5e-05	0.00086	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—FGFR3—cervical cancer	3.5e-05	0.00086	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—CTNNB1—cervical cancer	3.49e-05	0.000857	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3.48e-05	0.000854	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—FGFR3—cervical cancer	3.47e-05	0.000852	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—FGFR3—cervical cancer	3.44e-05	0.000845	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—FGFR3—cervical cancer	3.42e-05	0.000841	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TERT—cervical cancer	3.41e-05	0.000837	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	3.4e-05	0.000835	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—EGFR—cervical cancer	3.32e-05	0.000816	CbGpPWpGaD
Docetaxel—EGFR—Androgen receptor signaling pathway—STAT3—cervical cancer	3.3e-05	0.00081	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—FGFR3—cervical cancer	3.24e-05	0.000796	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—NOTCH2—cervical cancer	3.21e-05	0.000789	CbGpPWpGaD
Docetaxel—KIF11—Immune System—CTNNB1—cervical cancer	3.2e-05	0.000786	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TAAR6—cervical cancer	3.17e-05	0.000778	CbGpPWpGaD
Docetaxel—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	3.16e-05	0.000776	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—CASP3—cervical cancer	3.13e-05	0.00077	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—CASP8—cervical cancer	3.12e-05	0.000767	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	3.1e-05	0.000762	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TERT—cervical cancer	3.07e-05	0.000755	CbGpPWpGaD
Docetaxel—BCL2—Direct p53 effectors—TP53—cervical cancer	2.96e-05	0.000728	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—MTOR—cervical cancer	2.95e-05	0.000726	CbGpPWpGaD
Docetaxel—EGFR—ErbB1 downstream signaling—STAT3—cervical cancer	2.89e-05	0.00071	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CASP8—cervical cancer	2.88e-05	0.000708	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—MTOR—cervical cancer	2.83e-05	0.000694	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TERT—cervical cancer	2.82e-05	0.000693	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—FGFR3—cervical cancer	2.82e-05	0.000693	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	2.82e-05	0.000692	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	2.8e-05	0.000687	CbGpPWpGaD
Docetaxel—BCL2—Integrated Breast Cancer Pathway—TP53—cervical cancer	2.79e-05	0.000685	CbGpPWpGaD
Docetaxel—KIF11—Immune System—STAT3—cervical cancer	2.79e-05	0.000685	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—MTOR—cervical cancer	2.78e-05	0.000683	CbGpPWpGaD
Docetaxel—BCL2—Focal Adhesion—EGFR—cervical cancer	2.76e-05	0.000679	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.75e-05	0.000676	CbGpPWpGaD
Docetaxel—BCL2—Apoptosis—TP53—cervical cancer	2.73e-05	0.000671	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways in Glioblastoma—TP53—cervical cancer	2.69e-05	0.00066	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—MTOR—cervical cancer	2.66e-05	0.000653	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—NOTCH1—cervical cancer	2.65e-05	0.00065	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—MTOR—cervical cancer	2.64e-05	0.000649	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—MTOR—cervical cancer	2.64e-05	0.000649	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—MTOR—cervical cancer	2.63e-05	0.000646	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—MTOR—cervical cancer	2.62e-05	0.000643	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TERT—cervical cancer	2.58e-05	0.000634	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	2.58e-05	0.000634	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	2.57e-05	0.000632	CbGpPWpGaD
Docetaxel—KIF11—Immune System—EGFR—cervical cancer	2.53e-05	0.000623	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	2.48e-05	0.000609	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CA9—cervical cancer	2.48e-05	0.000608	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—WNT2—cervical cancer	2.47e-05	0.000607	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—MTOR—cervical cancer	2.46e-05	0.000605	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	2.46e-05	0.000605	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—MTOR—cervical cancer	2.46e-05	0.000605	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—MTOR—cervical cancer	2.44e-05	0.0006	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—MTOR—cervical cancer	2.42e-05	0.000594	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—MTOR—cervical cancer	2.41e-05	0.000592	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—FGFR3—cervical cancer	2.38e-05	0.000586	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—CASP3—cervical cancer	2.36e-05	0.00058	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—cervical cancer	2.36e-05	0.000579	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.31e-05	0.000568	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—FGFR3—cervical cancer	2.3e-05	0.000565	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—STAT3—cervical cancer	2.28e-05	0.000561	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—MTOR—cervical cancer	2.28e-05	0.00056	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DPB1—cervical cancer	2.25e-05	0.000552	CbGpPWpGaD
Docetaxel—EGFR—Immune System—UBE3A—cervical cancer	2.23e-05	0.000547	CbGpPWpGaD
Docetaxel—ABCC1—Disease—WNT2—cervical cancer	2.21e-05	0.000544	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DPB1—cervical cancer	2.19e-05	0.000538	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	2.18e-05	0.000536	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CASP3—cervical cancer	2.18e-05	0.000536	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKAP13—cervical cancer	2.17e-05	0.000533	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	2.13e-05	0.000524	CbGpPWpGaD
Docetaxel—EGFR—Disease—WNT2—cervical cancer	2.09e-05	0.000512	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—CTNNB1—cervical cancer	2.06e-05	0.000507	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	2.05e-05	0.000505	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—STAT3—cervical cancer	2.05e-05	0.000504	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—STAT3—cervical cancer	2.04e-05	0.000502	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—cervical cancer	2.01e-05	0.000494	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—NOTCH1—cervical cancer	1.99e-05	0.000489	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MTOR—cervical cancer	1.98e-05	0.000487	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CASP8—cervical cancer	1.97e-05	0.000483	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HES1—cervical cancer	1.92e-05	0.000471	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—STAT3—cervical cancer	1.9e-05	0.000468	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—WNT5A—cervical cancer	1.87e-05	0.00046	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TAAR6—cervical cancer	1.87e-05	0.00046	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—STAT3—cervical cancer	1.86e-05	0.000457	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CASP3—cervical cancer	1.82e-05	0.000448	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CTNNB1—cervical cancer	1.76e-05	0.000432	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DQB1—cervical cancer	1.75e-05	0.000431	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—cervical cancer	1.75e-05	0.00043	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CA9—cervical cancer	1.75e-05	0.00043	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DQB1—cervical cancer	1.71e-05	0.00042	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CA9—cervical cancer	1.69e-05	0.000416	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	1.69e-05	0.000414	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—MTOR—cervical cancer	1.68e-05	0.000412	CbGpPWpGaD
Docetaxel—ABCC1—Disease—WNT5A—cervical cancer	1.68e-05	0.000412	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—cervical cancer	1.65e-05	0.000405	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CTNNB1—cervical cancer	1.64e-05	0.000403	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CTNNB1—cervical cancer	1.64e-05	0.000403	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD8A—cervical cancer	1.64e-05	0.000402	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—MTOR—cervical cancer	1.62e-05	0.000398	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—cervical cancer	1.62e-05	0.000397	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD8A—cervical cancer	1.6e-05	0.000392	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CTNNB1—cervical cancer	1.58e-05	0.000389	CbGpPWpGaD
Docetaxel—EGFR—Disease—WNT5A—cervical cancer	1.58e-05	0.000388	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—CASP3—cervical cancer	1.54e-05	0.000379	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CA9—cervical cancer	1.54e-05	0.000378	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CTNNB1—cervical cancer	1.53e-05	0.000377	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—STAT3—cervical cancer	1.53e-05	0.000377	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CA9—cervical cancer	1.53e-05	0.000375	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—cervical cancer	1.51e-05	0.000372	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CTNNB1—cervical cancer	1.5e-05	0.000368	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—WNT2—cervical cancer	1.46e-05	0.000359	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NOTCH1—cervical cancer	1.45e-05	0.000355	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CTNNB1—cervical cancer	1.43e-05	0.000353	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.42e-05	0.000349	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—cervical cancer	1.39e-05	0.000342	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.37e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—FGFR3—cervical cancer	1.36e-05	0.000334	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CTNNB1—cervical cancer	1.35e-05	0.000331	CbGpPWpGaD
Docetaxel—BCL2—Immune System—FGFR3—cervical cancer	1.34e-05	0.000329	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DPB1—cervical cancer	1.33e-05	0.000326	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—FGFR3—cervical cancer	1.31e-05	0.000321	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—STAT3—cervical cancer	1.3e-05	0.000319	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—cervical cancer	1.3e-05	0.000319	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKAP13—cervical cancer	1.28e-05	0.000315	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—cervical cancer	1.23e-05	0.000302	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—cervical cancer	1.17e-05	0.000287	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CASP8—cervical cancer	1.16e-05	0.000286	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CASP8—cervical cancer	1.15e-05	0.000282	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—cervical cancer	1.14e-05	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—WNT5A—cervical cancer	1.11e-05	0.000272	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CA9—cervical cancer	1.1e-05	0.000271	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.08e-05	0.000264	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—cervical cancer	1.07e-05	0.000264	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQB1—cervical cancer	1.04e-05	0.000255	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.04e-05	0.000255	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MTHFR—cervical cancer	1e-05	0.000247	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—cervical cancer	9.83e-06	0.000241	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD8A—cervical cancer	9.69e-06	0.000238	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HES1—cervical cancer	9.65e-06	0.000237	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—cervical cancer	9.61e-06	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MTOR—cervical cancer	9.57e-06	0.000235	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—cervical cancer	9.55e-06	0.000235	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MTOR—cervical cancer	9.43e-06	0.000232	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—cervical cancer	9.41e-06	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MTOR—cervical cancer	9.19e-06	0.000226	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—cervical cancer	9.17e-06	0.000225	CbGpPWpGaD
Docetaxel—EGFR—Disease—HES1—cervical cancer	9.1e-06	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—cervical cancer	8.48e-06	0.000208	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTHFR—cervical cancer	8.48e-06	0.000208	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TERT—cervical cancer	8.46e-06	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—cervical cancer	8.37e-06	0.000206	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—cervical cancer	8.36e-06	0.000205	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CA9—cervical cancer	8.33e-06	0.000205	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	8.22e-06	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTHFR—cervical cancer	7.99e-06	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Disease—TERT—cervical cancer	7.97e-06	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Immune System—FGFR3—cervical cancer	7.92e-06	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH2—cervical cancer	7.77e-06	0.000191	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGFR3—cervical cancer	7.76e-06	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGFR3—cervical cancer	7.31e-06	0.00018	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOTCH1—cervical cancer	7.29e-06	0.000179	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—cervical cancer	7.29e-06	0.000179	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—cervical cancer	7.1e-06	0.000174	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.9e-06	0.000169	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—cervical cancer	6.87e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOTCH1—cervical cancer	6.87e-06	0.000169	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CASP8—cervical cancer	6.77e-06	0.000166	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—cervical cancer	6.62e-06	0.000163	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—cervical cancer	6.37e-06	0.000156	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—cervical cancer	6.25e-06	0.000154	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—cervical cancer	6.19e-06	0.000152	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TERT—cervical cancer	5.58e-06	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MTOR—cervical cancer	5.57e-06	0.000137	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—cervical cancer	5.56e-06	0.000137	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTOR—cervical cancer	5.46e-06	0.000134	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—cervical cancer	5.45e-06	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTOR—cervical cancer	5.15e-06	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—cervical cancer	5.14e-06	0.000126	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA9—cervical cancer	5.13e-06	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGFR3—cervical cancer	5.12e-06	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—cervical cancer	4.94e-06	0.000121	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—cervical cancer	4.84e-06	0.000119	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH1—cervical cancer	4.81e-06	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—cervical cancer	4.56e-06	0.000112	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—cervical cancer	4.48e-06	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—cervical cancer	4.31e-06	0.000106	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—cervical cancer	4.22e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—cervical cancer	3.98e-06	9.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—cervical cancer	3.83e-06	9.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTOR—cervical cancer	3.6e-06	8.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—cervical cancer	3.38e-06	8.3e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—cervical cancer	3.31e-06	8.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—cervical cancer	3.19e-06	7.85e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—cervical cancer	2.78e-06	6.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—cervical cancer	2.13e-06	5.22e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—cervical cancer	2.08e-06	5.11e-05	CbGpPWpGaD
